Study reveals cost differences between Medicare Advantage and traditional Medicare patients in cancer drugs
A new study examining the use of high-cost drugs among patients with colorectal cancer and non-small cell lung cancer found ...
JD Supra2h
Adapting to the IRA: Early Lessons Learned on the IRA’s Impact on Deal-Making, Drug Economics, and Business Strategy
More than two years after the passage of the Inflation Reduction Act (“IRA”) and the Centers for Medicare and Medicaid Services’ (“CMS’”) ...
Healio10h
Combination extends survival vs. standard first-line therapy for advanced lung cancer
A two-drug combination extended OS compared with standard first-line osimertinib for certain patients with advanced lung ...
What's the strongest OTC anti-inflammatory? Experts compare naproxen, ibuprofen
If you’re looking for an OTC medication that’ll ease pain and quell inflammation, there are several great options to choose ...
pharmaphorum20h
Pharma’s climate change vulnerability and opportunity
“The pharmaceutical industry is globalized: generic drugs manufactured at sites in India will be produced using imported materials and be shipped to distributors worldwide, who will coordinate ...